<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2017.7162</article-id>
<article-id pub-id-type="publisher-id">mmr-16-04-4980</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Knockdown of Hotair suppresses proliferation and cell cycle progression in hepatocellular carcinoma cell by downregulating CCND1 expression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Jia-Jia</given-names></name>
<xref rid="af1-mmr-16-04-4980" ref-type="aff">1</xref>
<xref rid="fn1-mmr-16-04-4980" ref-type="author-notes">&#x002A;</xref>
<xref rid="c1-mmr-16-04-4980" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Di</given-names></name>
<xref rid="af1-mmr-16-04-4980" ref-type="aff">1</xref>
<xref rid="fn1-mmr-16-04-4980" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>He</surname><given-names>Xiao-Yu</given-names></name>
<xref rid="af2-mmr-16-04-4980" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Meng</surname><given-names>Zhe</given-names></name>
<xref rid="af1-mmr-16-04-4980" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Wen-Zhu</given-names></name>
<xref rid="af1-mmr-16-04-4980" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Ru-Fu</given-names></name>
<xref rid="af1-mmr-16-04-4980" ref-type="aff">1</xref></contrib>
</contrib-group>
<aff id="af1-mmr-16-04-4980"><label>1</label>Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, P.R. China</aff>
<aff id="af2-mmr-16-04-4980"><label>2</label>Laboratory of Biomechanics and Physiology, Guangdong Provincial Institute of Sports Science, Guangzhou, Guangdong 510663, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-16-04-4980"><italic>Correspondence to</italic>: Dr Jia-Jia Zhou, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 West Yan Jiang Road, Guangzhou, Guangdong 510120, P.R. China, E-mail: <email>jiajiazh2004@126.com</email></corresp>
<fn id="fn1-mmr-16-04-4980"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub"><month>10</month><year>2017</year></pub-date>
<pub-date pub-type="epub"><day>03</day><month>08</month><year>2017</year></pub-date>
<volume>16</volume>
<issue>4</issue>
<fpage>4980</fpage>
<lpage>4986</lpage>
<history>
<date date-type="received"><day>24</day><month>10</month><year>2016</year></date>
<date date-type="accepted"><day>14</day><month>06</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017, Spandidos Publications</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>The long noncoding RNA, homeobox transcript antisense RNA (Hotair), has been demonstrated to have an important role in regulating various biological processes in various cancers, including hepatocellular carcinoma (HCC). However, the importance of Hotair in HCC proliferation and cell cycle progression remains to be elucidated. In the present study, knockdown of <italic>HOTAIR</italic> expression by RNA interference inhibited cell proliferation and induced G0/G1 cell cycle arrest in Huh7 hepatocellular carcinoma cells. In addition, the expression levels of <italic>CCND1</italic> mRNA and its cyclin D1 protein product were reduced in Huh7 cells following knockdown of <italic>HOTAIR</italic>. Knockdown of <italic>HOTAIR</italic> reduced the expression of phosphorylated signal transducer and activator of transcription 3 (STAT3) and <italic>HOTAIR</italic> knockdown combined with STAT3 inhibition led to an additional decrease in cyclin D1 expression. The present study suggested that Hotair may have a critical role in the proliferation of HCC by regulating cell cycle, STAT3 activity and cyclin D1 expression. Therefore, Hotair may be a novel potential therapeutic target for HCC treatment.</p>
</abstract>
<kwd-group>
<kwd>hepatocellular carcinoma</kwd>
<kwd>homeobox transcript antisense RNA</kwd>
<kwd>proliferation</kwd>
<kwd>cell cycle</kwd>
<kwd><italic>CCND1</italic> gene</kwd>
<kwd>signal transducer and activator of transcription 3</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Hepatocellular carcinoma (HCC) is currently one of the most common malignant tumors worldwide and the morbidity and mortality associated with HCC are high, which may be in part due to late diagnosis, by which time cancer progression is quite advanced (<xref rid="b1-mmr-16-04-4980" ref-type="bibr">1</xref>). Previous studies have demonstrated that long noncoding RNAs (lncRNAs) have an important role in the regulation of various biological processes in cancers, including proliferation, metastasis, cancer progression and epithelial-to-mesenchymal transition (<xref rid="b2-mmr-16-04-4980" ref-type="bibr">2</xref>,<xref rid="b3-mmr-16-04-4980" ref-type="bibr">3</xref>). Therefore, investigation of the roles of lncRNAs in carcinogenesis and the progression of HCC is required.</p>
<p>Human lncRNA, homeobox transcript antisense intergenic RNA (Hotair), a 2.2 kb RNA transcribed from the Hoxc locus, interacts with both polycomb repressive complex (PRC2) and lysine-specific histone demethylase 1A complexes to enhance histone H3 lysine trimethylation and histone H3 lysine 4 demethylation, leading to the silencing of multiple genes (<xref rid="b3-mmr-16-04-4980" ref-type="bibr">3</xref>,<xref rid="b4-mmr-16-04-4980" ref-type="bibr">4</xref>). A previous study determined that Hotair was upregulated in breast cancer and associated with cancer invasiveness and metastasis (<xref rid="b3-mmr-16-04-4980" ref-type="bibr">3</xref>). Subsequent studies revealed that Hotair promotes proliferation and reduces apoptosis in pancreatic cancer, colorectal cancer and glioma cells (<xref rid="b5-mmr-16-04-4980" ref-type="bibr">5</xref>&#x2013;<xref rid="b7-mmr-16-04-4980" ref-type="bibr">7</xref>). In addition, it has been reported that Hotair was overexpressed in HCC and this was positively associated with poor prognosis, tumor progression and recurrence of HCC, suggesting that Hotair functions as an oncogene (<xref rid="b8-mmr-16-04-4980" ref-type="bibr">8</xref>,<xref rid="b9-mmr-16-04-4980" ref-type="bibr">9</xref>). However, the potential role of Hotair in regulating cell proliferation and cell cycle progression in HCC and the underlying molecular mechanism remain to be fully elucidated.</p>
<p>Cell proliferation is associated with cell cycle progression. Cell cycle is divided into G0/G1, S and G2/M phases, which are controlled by various cyclin-dependent kinases (CDKs) (<xref rid="b10-mmr-16-04-4980" ref-type="bibr">10</xref>,<xref rid="b11-mmr-16-04-4980" ref-type="bibr">11</xref>). The critical regulation point of the cell cycle is the G1 checkpoint. Cyclin D1 (encoded by the <italic>CCND1</italic> gene), is a G1 cyclin and is an important for regulating the transition of G1 to S (G1-S) in different cell types (<xref rid="b11-mmr-16-04-4980" ref-type="bibr">11</xref>). By cooperating with its binding partners CDK4 and CDK6, cyclin D1 promoted the phosphorylation of retinoblastoma protein, leading to the activation of E2F transcription factors; therefore, enabling cell cycle progression through G1 into the S phase (<xref rid="b11-mmr-16-04-4980" ref-type="bibr">11</xref>). <italic>CCND1</italic> overexpression is commonly observed in various types of human cancers, including HCC, and serves a critical role in the initiation of carcinogenesis (<xref rid="b12-mmr-16-04-4980" ref-type="bibr">12</xref>). <italic>CCND1</italic> is also involved in abnormal cell growth processes, angiogenesis and resistance to apoptosis, making it a potential therapeutic target for controlling tumor growth (<xref rid="b13-mmr-16-04-4980" ref-type="bibr">13</xref>,<xref rid="b14-mmr-16-04-4980" ref-type="bibr">14</xref>). However, the association of Hotair and <italic>CCND1</italic> expression in HCC remains unclear.</p>
<p>In the present study, the potential role of Hotair in regulating proliferation and <italic>CCND1</italic> expression in the Huh7 HCC cell line was investigated. Knockdown of <italic>HOTAIR</italic> inhibited cell proliferation and blocked the cell cycle at the G0/G1 checkpoint by reducing <italic>CCND1</italic> and cyclin D1 expression and this effect was enhanced by the inhibition of signal transducer and activator of transcription 3 (STAT3). These findings may provide an insight into the underlying mechanism of Hotair in regulating cell proliferation and cell cycle progression of HCC and suggest that Hotair may be a potential therapeutic target for HCC treatment.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Cell line and culture</title>
<p>The human Huh7 hepatocellular carcinoma cell line was purchased from the American Type Culture Collection (Manassas, VA, USA). Cells were maintained in Dulbecco&#x0027;s modified Eagle&#x0027;s medium supplemented with 10&#x0025; fetal bovine serum (Hyclone; GE Healthcare, Logan, UT, USA) at 37&#x00B0;C in an atmosphere of 5&#x0025; CO<sub>2</sub> with humidity. The culture medium was changed every 24 h. Cells were treated with 50 &#x00B5;M AG490 (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) and incubated in a humidified chamber supplemented with 5&#x0025; CO<sub>2</sub> at 37&#x00B0;C for 48 h.</p>
</sec>
<sec>
<title>Hotair siRNA transfection</title>
<p>Knockdown of human <italic>HOTAIR</italic> (Gene ID, 100124700) was achieved by transfection of small interfering RNA (siRNA). The siRNA sequences were as follows: <italic>HOTAIR</italic>, 5&#x2032;- UAACAAGACCAGAGAGCUGUU &#x2212;3&#x2032; and negative control (NC), 5&#x2032;-TTCTCCGAACGTGTCACGT-3&#x2032;. The sequences of siRNA were previously described (<xref rid="b8-mmr-16-04-4980" ref-type="bibr">8</xref>,<xref rid="b15-mmr-16-04-4980" ref-type="bibr">15</xref>) and were synthesized by Shanghai GenePharma Co., Ltd. (Shanghai, China). Cells were seeded in 24-well culture dishes at a density of 10<sup>5</sup> cells/well and incubated in a humidified chamber supplemented with 5&#x0025; CO<sub>2</sub> at 37&#x00B0;C. siRNA (2 &#x00B5;M) transfection was performed using Lipofectamine&#x2122; 3000 (1 &#x00B5;M) (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 25 min at room temperature according to the manufacturer&#x0027;s protocol. After transfection, cells were incubated in a humidified chamber supplemented with 5&#x0025; CO<sub>2</sub> at 37&#x00B0;C for 48 h. Mock-transfected cells were transfected with Lipofectamine&#x2122; 3000 without siRNA.</p>
</sec>
<sec>
<title>Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)</title>
<p>RT-qPCR was performed to determine the expression levels of lncRNA <italic>HOTAIR</italic> and the mRNA expression of <italic>CCND1</italic>. Briefly, 24 h after transfection, total RNA of the cells was harvested using RNAiso Plus reagent (Takara Biotechnology Co., Ltd., Dalian, China). Total RNA was reverse transcribed into cDNA using PrimeScript&#x2122; RT Reagent kit with gDNA Eraser (Takara Biotechnology Co., Ltd.). Thermocycling conditions were as follows: At 37&#x00B0;C for 15 min, at 85&#x00B0;C for 5 sec to inactivate the enzyme, and cooling at 37&#x00B0;C for 1 min. qPCR was performed on cDNA using SYBR<sup>&#x00AE;</sup> Premix Ex Taq&#x2122; II (Takara Biotechnology Co., Ltd.). The reaction volume was 25 &#x00B5;l, containing SBYR Premix Ex Taq II (12.5 &#x00B5;l), 1 &#x00B5;l of each forward and reverse primer, cDNA (2 &#x00B5;l) and dH<sub>2</sub>O (8.5 &#x00B5;l). Thermocycling conditions were as follows: Initial denaturation at 95&#x00B0;C for 5 min, followed by 40 cycles of denaturation at 95&#x00B0;C for 20 sec, annealing at 58&#x00B0;C for 30 sec and elongation at 72&#x00B0;C for 30 sec. The relative expression levels of <italic>CCND1</italic> mRNA and lncRNA <italic>HOTAIR</italic> were calculated according to the comparative Cq method and normalized to <italic>GAPDH</italic> expression (<xref rid="b16-mmr-16-04-4980" ref-type="bibr">16</xref>). The following primers were used in the present study: <italic>HOTAIR</italic>, forward 5&#x2032;-CAGTGGGGAACTCTGACTCG-3&#x2032;, reverse 5&#x2032;-GTGCCTGGTGCTCTCTTACC-3&#x2032;; <italic>CCND1</italic>, forward 5&#x2032;-CCGCCTCACACGCTTCCTCTC-3&#x2032;, reverse 5&#x2032;-CGGCCTTGGGGTCCATGTTCT-3&#x2032;; <italic>GAPDH</italic>, forward 5&#x2032;-GCACCGTCAAGGCTGAGAAC-3&#x2032;, reverse 5&#x2032;-TGGTGAAGACGCCAGTGGA-3&#x2032;.</p>
</sec>
<sec>
<title>Western blotting</title>
<p>After 48 h transfection, the cells were lysed with radioimmunoprecipitation assay lysis buffer (Cell Signaling Technology, Inc., Danvers, MA, USA) in the presence of protease/phosphatase inhibitor cocktail (Cell Signaling Technology, Inc.) at 4&#x00B0;C for 30 min, and the lysates were centrifuged at 12,000 &#x00D7; g at 4&#x00B0;C for 20 min. The concentration of protein was measured using a bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Inc.). Equal amounts (30 &#x00B5;g) of extracted protein samples were separated by 10&#x0025; SDS-PAGE and transferred onto polyvinylidene difluoride membranes (EMD Millipore, Billerica, MA, USA). After blocking with 5&#x0025; non-fat milk for 2 h at room temperature, the membranes were incubated with the following primary antibodies at 4&#x00B0;C under gentle agitation overnight: Rabbit monoclonal cyclin D1 antibody (1:10,000; cat no. ab134175; Abcam, Cambridge, UK), rabbit polyclonal phosphorylated (p)-STAT3 (Tyr705) antibody (1:2,000; cat no. 9145; Cell Signaling Technology, Inc.), mouse monoclonal STAT3 antibody (1:1,000; cat no. 9139; Cell Signaling Technology, Inc.) and mouse monoclonal GAPDH antibody (1:1,000; cat no. sc-47724; Santa Cruz Biotechnology, Inc., Dallas, TX, USA). Subsequently, membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit (cat no. SA00001-2) or goat anti-mouse (cat no. SA00001-1) antibodies (1:5,000; ProteinTech Group, Inc., Chicago, IL, USA) for 2 h at room temperature under gentle agitation. Protein bands were visualized using the Supersignal<sup>&#x00AE;</sup> West Pico Chemiluminescent substrate (Thermo Fisher Scientific, Inc.) on X-ray films. Blots were semi-quantified by densitometric analysis using ImageJ software version 1.51 (National Institutes of Health, Bethesda, MD, USA).</p>
</sec>
<sec>
<title>Cell proliferation assay</title>
<p>Cell proliferation assay was performed using a Cell Counting Kit-8 (CCK-8; Dojindo Molecular Technologies, Inc., Kumamoto, Japan) assay. Cells were seeded in 96-well plates (Corning Inc., Corning, NY, USA) at a density of 10<sup>4</sup> cells/well and incubated in a humidified chamber supplemented with 5&#x0025; CO<sub>2</sub> at 37&#x00B0;C. The CCK-8 assay was used to detect the viability of cells following the manufacturer&#x0027;s protocol. CCK-8 solution (10 &#x00B5;l) was added in each well and cells were incubated in a humidified chamber supplemented with 5&#x0025; CO<sub>2</sub> at 37&#x00B0;C for 1 h. The absorbance was measured at a wavelength of 450 nm using a microplate reader. Six replicate wells were used for each group.</p>
</sec>
<sec>
<title>Cell cycle analysis</title>
<p>The cell cycle profile was analyzed using flow cytometry. Briefly, 1&#x00D7;10<sup>6</sup> cells were harvested and fixed with ice-cold 75&#x0025; ethanol at 4&#x00B0;C overnight and incubated with propidium iodide (PI; 50 &#x00B5;g/ml; Sigma-Aldrich, Merck KGaA) in the dark at room temperature for 30 min. Flow cytometric analysis was performed on a Beckman Coulter EPICS analyzer (Beckman Coulter, Inc., Brea, CA, USA). Multicycle AV software version 3.0 (Phoenix Flow Systems, San Diego, CA, USA) was employed for calculating the cell cycle phase distribution from the resultant DNA histogram.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Data are presented as mean &#x00B1; standard deviation of 3 independent experiments. Statistical analysis was performed using using SPSS software version 13.0 (SPSS, Inc., Chicago, IL, USA). The statistical significance of the differences between groups was assessed using a two-tailed Student&#x0027;s t-test or one-way analysis of variance followed by a Tukey post hoc test. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Knockdown of HOTAIR by specific siRNA</title>
<p>In order to investigate the potential role of Hotair in HCC, specific siRNA targeting <italic>HOTAIR</italic> was used to transfect Huh7 hepatocarcima cells to silence <italic>HOTAIR</italic> expression. Transfection of Huh7 cells with <italic>HOTAIR</italic> siRNA resulted in significant knockdown of <italic>HOTAIR</italic> expression compared with the siNC group (P&#x003C;0.05; <xref rid="f1-mmr-16-04-4980" ref-type="fig">Fig. 1A</xref>). NC siRNA had no significant impact on the expression level of <italic>HOTAIR</italic> compared with the Mock cells.</p>
</sec>
<sec>
<title>Knockdown of HOTAIR inhibits proliferation of Huh7 cells</title>
<p>The role of Hotair on the prolferation of Huh7 cells, was examined by determining the effect of <italic>HOTAIR</italic> siRNA on cell growth. The proliferation of <italic>HOTAIR</italic> knockdown cells was significantly reduced compared with the siNC and Mock cells at 36, 48 and 72 h post-transfection (P&#x003C;0.05; <xref rid="f1-mmr-16-04-4980" ref-type="fig">Fig. 1B</xref>).</p>
</sec>
<sec>
<title>Knockdown of HOTAIR arrests the cell cycle of Huh7 cells</title>
<p>To evaluate whether Hotair has a role in the regulation of cell cycle progression of Huh7 cells, the cell cycle phases of <italic>HOTAIR</italic> knockdown cells were analyzed. The present study determined that the cell cycle was primarily blocked at the G0/G1 checkpoint in the <italic>HOTAIR</italic> knock-down cells, compared with the NC and Mock cells. In the <italic>HOTAIR</italic> knockdown cells, the G0/G1 ratio was significantly higher and the proportion of cells in S &#x002B; G2/M was significantly lower than the NC and Mock cells (P&#x003C;0.05; <xref rid="f2-mmr-16-04-4980" ref-type="fig">Fig. 2</xref>).</p>
</sec>
<sec>
<title>Knockdown of HOTAIR decreases expression of CCND1 in Huh7 cells</title>
<p>To evaluate the role of Hotair on the proliferation and cell cycle of Huh7 cells, the expression level of a key regulator of the G1-S phase transition, <italic>CCND1</italic>, was measured. <italic>CCND1</italic> expression was positively associated with <italic>HOTAIR</italic> expression in Huh7 cells. Compared with the siNC group, the mRNA expression levels of <italic>CCND1</italic> (<xref rid="f3-mmr-16-04-4980" ref-type="fig">Fig. 3A</xref>) and its cyclin D1 protein product (<xref rid="f3-mmr-16-04-4980" ref-type="fig">Fig. 3B and C</xref>) were significantly reduced in <italic>HOTAIR</italic> knockdown cells (P&#x003C;0.05).</p>
</sec>
<sec>
<title>Knockdown of HOTAIR inhibits expression of pSTAT3 in Huh7 cells</title>
<p>As cyclin D1 has been demonstrated to be a downstream target of STAT3, the present study investigated whether Hotair regulated cyclin D1 expression via the STAT3 signaling pathway. Compared with the siNC group, the protein expression levels of cyclin D1 and phosphorylated (p) STAT3 were significantly reduced in <italic>HOTAIR</italic> knockdown cells (P&#x003C;0.05; <xref rid="f4-mmr-16-04-4980" ref-type="fig">Fig. 4</xref>). However, the expression level of total STAT3 was not affected in the <italic>HOTAIR</italic> knockdown cells, compared with the siNC group.</p>
</sec>
<sec>
<title>Knockdown of HOTAIR combined with STAT3 inhibition leads to an additional decrease in CCND1 expression</title>
<p>To further explore the effect of Hotair and STAT3 signaling on cyclin D1 expression. Huh7 cells were treated with the STAT3 inhibitor, AG490, for 1 h prior to <italic>HOTAIR</italic> siRNA transfection. Cyclin D1 and pSTAT3 expression levels were suppressed following AG490 treatment in cells transfected with or without siHotair; however, the suppresion was greater in the cells treated with AG490 and <italic>HOTAIR</italic> siRNA in combination (P&#x003C;0.05, <xref rid="f5-mmr-16-04-4980" ref-type="fig">Fig. 5</xref>). Overall, the data suggested that reduced <italic>HOTAIR</italic> expression was associated with reduced cyclin D1 expression and STAT3 phosphorylation. Knockdown of <italic>HOTAIR</italic> combined with STAT3 inhibition led to an additional decrease in cyclin D1 expression and STAT3 phosphorylation compared with individual treatments.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The G1/S phase transition in the cell cycle is crucial for unlimited cell proliferation and tumor growth. A previous study revealed that several lncRNAs appear to be correlated with aberrant proliferation of cancer cells (<xref rid="b17-mmr-16-04-4980" ref-type="bibr">17</xref>). In the present study, knockdown of lncRNA <italic>HOTAIR</italic> suppressed cell proliferation and inhibited G1/S phase transition of cell cycle.</p>
<p>Unlimited proliferation is a feature of cancer and is associated with aberrant cell cycle progression (<xref rid="b18-mmr-16-04-4980" ref-type="bibr">18</xref>,<xref rid="b19-mmr-16-04-4980" ref-type="bibr">19</xref>). Dysregulation of the G1/S phase transition may lead to unlimited cell proliferation (<xref rid="b11-mmr-16-04-4980" ref-type="bibr">11</xref>,<xref rid="b12-mmr-16-04-4980" ref-type="bibr">12</xref>). A previous study revealed that Hotair was overexpressed in HCC specimens, and in HepG2 and Huh7 cell lines (<xref rid="b8-mmr-16-04-4980" ref-type="bibr">8</xref>). In the present study, knockdown of <italic>HOTAIR</italic> led to the inhibition of cell proliferation of Huh7 cells. Furthermore, flow cytometric analysis demonstrated that knockdown of <italic>HOTAIR</italic> increased the percentage of cells in the G0/G1 phase and reduced the percentage of Huh7 cells in the S &#x002B; G2/M phase. These findings suggested that Hotair may be a novel regulator of the G1/S phase transition and cell proliferation in HCC cells. Cyclin D1 protein (encoded by the <italic>CCND1</italic> gene) is considered to be a critical regulator in G1-S phase transition, and cyclin D1 and Hotair were overexpressed in HCC (<xref rid="b8-mmr-16-04-4980" ref-type="bibr">8</xref>,<xref rid="b12-mmr-16-04-4980" ref-type="bibr">12</xref>). Therefore, the present study investigated the effect of Hotair on <italic>CCND1</italic> and cyclin D1 expression. Indeed, knockdown of <italic>HOTAIR</italic> resulted in a reduction in the <italic>CCND1</italic> protein and mRNA expression levels, suggesting that Hotair is an upstream regulator of cyclin D1 expression. Collectively, this data may shed light on the potential role of Hotair in promoting HCC development and progression and the regulation of proliferation and cell cycle progression, via cyclin D1 expression, and suggests that Hotair may be a potential therapeutic target for HCC treatment. In addition, Hotair has been reported to promote tumorigenesis, metastasis and drug resistance in multiple cancer types, including HCC (<xref rid="b3-mmr-16-04-4980" ref-type="bibr">3</xref>,<xref rid="b8-mmr-16-04-4980" ref-type="bibr">8</xref>), suggesting that targeting Hotair as part of HCC treatment would be more beneficial than only direct inhibition of cyclin D1. However, further studies are required to confirm this.</p>
<p>The potential underlying molecular mechanism by which Hotair regulates cyclin D1 expression was investigated in the present study. <italic>CCND1</italic> overexpression may occur due to constitutive activation of STAT3, a transcription factor that participates in cytokine signaling (<xref rid="b20-mmr-16-04-4980" ref-type="bibr">20</xref>). It has been previously demonstrated that STAT3 is constitutively activated by phosphorylation of tyrosine residues in HCC and its activation may be associated with unlimited cell proliferation of cancer cells (<xref rid="b20-mmr-16-04-4980" ref-type="bibr">20</xref>). In the present study, knockdown of <italic>HOTAIR</italic> inhibited STAT3 phosphorylation and reduced cyclin D1 expression. In addition, knockdown of <italic>HOTAIR</italic> combined with STAT3 inhibition led to an additional decrease in cyclin D1 expression, suggesting that STAT3 activation may have a mechanistic role in Hotair-mediated cyclin D1 expression and proliferation in HCC cells. Previous studies have demonstrated that Hotair interacts with the PRC2 complex, which is composed of subunits enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2), SUZ12 polycomb repressive complex 2 subunit and embryonic ectoderm development (EED) (<xref rid="b21-mmr-16-04-4980" ref-type="bibr">21</xref>,<xref rid="b6-mmr-16-04-4980" ref-type="bibr">6</xref>). EZH2 binds to and methylates STAT3, leading to increased STAT3 activity by increasing tyrosine phosphorylation of STAT3. Inhibition of EZH2 reverses the silencing of Polycomb target genes and reduces STAT3 activity (<xref rid="b22-mmr-16-04-4980" ref-type="bibr">22</xref>). Together with these studies, it was hypothesized in the present study, that lncRNA Hotair may activate STAT3 via EZH2/STAT3 signaling. Therefore, the data in the current study may partially explain the association between Hotair and <italic>CCND1</italic> expression in HCC and also reveal the underlying mechanism of Hotair regulation of proliferation and cell cycle progression of HCC through activation of EZH2/STAT3/cyclin D1 signaling. In addition, Liu <italic>et al</italic> (<xref rid="b23-mmr-16-04-4980" ref-type="bibr">23</xref>) demonstrated that STAT3 increased Hotair expression, suggesting that there may be a positive feedback loop between Hotair and STAT3, which may explain why a knockdown of <italic>HOTAIR</italic> combined with STAT3 inhibition led to additional decreases in cyclin D1 expression and STAT3 phosphorylation compared with individual treatments.</p>
<p>In addition, a previous study revealed a novel association between STAT3 activation and self-renewal modulation in cancer stem cells (CSCs) (<xref rid="b24-mmr-16-04-4980" ref-type="bibr">24</xref>). STAT3-mediated Nanog expression was vital for liver CSCs in driving self-renewal and tumor initiation (<xref rid="b23-mmr-16-04-4980" ref-type="bibr">23</xref>). Our previous study demonstrated that hepatitis C virus core regulated Nanog expression via activating STAT3 (<xref rid="b25-mmr-16-04-4980" ref-type="bibr">25</xref>), and Hotair was expressed in CSCs and promoted malignant growth of liver CSCs (<xref rid="b26-mmr-16-04-4980" ref-type="bibr">26</xref>). These findings suggested that activation of STAT3 by Hotair, may promote proliferation and cell cycle progression and modulate self-renewal of CSCs; therefore, Hotair may have a potential role in the modulation of the formation of CSCs and promoting HCC carcinogenesis and progression.</p>
<p>In conclusion, the present study revealed that Hotair was a novel regulator of the G1/S phase transition and proliferation in HCC cells by regulation of cyclin D1 expression and STAT3 singling. Despite the absence of an <italic>in vivo</italic> experiments and further studies that investigate whether Hotair regulates STAT3 activation via EZH2, the findings of the present study provide a novel insight into the mechanism of lncRNA-mediated hepatocarcinogenesis, and indicated that Hotair may be a promising therapeutic target for the inhibition of cell proliferation in HCC.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The current study was supported by National Natural Science Foundation of China (grant no. 81000889), Natural Science Foundation of Guangdong Province, China (grant no. 2016A030313218), Science and Technology Planning Project of Guangdong Province, China (grant no. 2014A020212094). This work was also supported by Grant (2013) 163 from Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; grant no. KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-16-04-4980"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname><given-names>K</given-names></name></person-group><article-title>Hepatocellular carcinoma</article-title><source>J Hepatol</source><volume>32</volume><supplement>1 Suppl</supplement><fpage>S225</fpage><lpage>S237</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S0168-8278(00)80428-6</pub-id></element-citation></ref>
<ref id="b2-mmr-16-04-4980"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>TR</given-names></name><name><surname>Dinger</surname><given-names>ME</given-names></name><name><surname>Mattick</surname><given-names>JS</given-names></name></person-group><article-title>Long non-coding RNAs: Insights into functions</article-title><source>Nat Rev Genet</source><volume>10</volume><fpage>155</fpage><lpage>159</lpage><year>2009</year><pub-id pub-id-type="doi">10.1038/nrg2521</pub-id><pub-id pub-id-type="pmid">19188922</pub-id></element-citation></ref>
<ref id="b3-mmr-16-04-4980"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>RA</given-names></name><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>KC</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Horlings</surname><given-names>HM</given-names></name><name><surname>Wong</surname><given-names>DJ</given-names></name><name><surname>Tsai</surname><given-names>MC</given-names></name><name><surname>Hung</surname><given-names>T</given-names></name><name><surname>Argani</surname><given-names>P</given-names></name><name><surname>Rinn</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis</article-title><source>Nature</source><volume>464</volume><fpage>1071</fpage><lpage>1076</lpage><year>2010</year><pub-id pub-id-type="doi">10.1038/nature08975</pub-id><pub-id pub-id-type="pmid">20393566</pub-id><pub-id pub-id-type="pmcid">3049919</pub-id></element-citation></ref>
<ref id="b4-mmr-16-04-4980"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinn</surname><given-names>JL</given-names></name><name><surname>Kertesz</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>JK</given-names></name><name><surname>Squazzo</surname><given-names>SL</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Brugmann</surname><given-names>SA</given-names></name><name><surname>Goodnough</surname><given-names>LH</given-names></name><name><surname>Helms</surname><given-names>JA</given-names></name><name><surname>Farnham</surname><given-names>PJ</given-names></name><name><surname>Segal</surname><given-names>E</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name></person-group><article-title>Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs</article-title><source>Cell</source><volume>129</volume><fpage>1311</fpage><lpage>1323</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.cell.2007.05.022</pub-id><pub-id pub-id-type="pmid">17604720</pub-id><pub-id pub-id-type="pmcid">2084369</pub-id></element-citation></ref>
<ref id="b5-mmr-16-04-4980"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Jutooru</surname><given-names>I</given-names></name><name><surname>Chadalapaka</surname><given-names>G</given-names></name><name><surname>Johnson</surname><given-names>G</given-names></name><name><surname>Frank</surname><given-names>J</given-names></name><name><surname>Burghardt</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Safe</surname><given-names>S</given-names></name></person-group><article-title>HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer</article-title><source>Oncogene</source><volume>32</volume><fpage>1616</fpage><lpage>1625</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/onc.2012.193</pub-id><pub-id pub-id-type="pmid">22614017</pub-id></element-citation></ref>
<ref id="b6-mmr-16-04-4980"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kogo</surname><given-names>R</given-names></name><name><surname>Shimamura</surname><given-names>T</given-names></name><name><surname>Mimori</surname><given-names>K</given-names></name><name><surname>Kawahara</surname><given-names>K</given-names></name><name><surname>Imoto</surname><given-names>S</given-names></name><name><surname>Sudo</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>F</given-names></name><name><surname>Shibata</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Komune</surname><given-names>S</given-names></name><etal/></person-group><article-title>Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers</article-title><source>Cancer Res</source><volume>71</volume><fpage>6320</fpage><lpage>6326</lpage><year>2011</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-1021</pub-id><pub-id pub-id-type="pmid">21862635</pub-id></element-citation></ref>
<ref id="b7-mmr-16-04-4980"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name></person-group><article-title>Magnetofection based on superparamagnetic iron oxide nanoparticle-mediated low lncRNA HOTAIR expression decreases the proliferation and invasion of glioma stem cells</article-title><source>Int J Oncol</source><volume>49</volume><fpage>509</fpage><lpage>518</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/ijo.2016.3571</pub-id><pub-id pub-id-type="pmid">27277755</pub-id><pub-id pub-id-type="pmcid">4922836</pub-id></element-citation></ref>
<ref id="b8-mmr-16-04-4980"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>WM</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>WM</given-names></name><name><surname>Lu</surname><given-names>YF</given-names></name><name><surname>Hu</surname><given-names>BG</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liang</surname><given-names>WC</given-names></name><name><surname>Wang</surname><given-names>SS</given-names></name><name><surname>Ko</surname><given-names>CH</given-names></name><name><surname>Waye</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling</article-title><source>J Hepatol</source><volume>63</volume><fpage>886</fpage><lpage>895</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.jhep.2015.05.016</pub-id><pub-id pub-id-type="pmid">26024833</pub-id></element-citation></ref>
<ref id="b9-mmr-16-04-4980"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>JZ</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>DU</surname><given-names>JL</given-names></name><name><surname>Li</surname><given-names>XL</given-names></name></person-group><article-title>Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrence</article-title><source>Oncol Lett</source><volume>11</volume><fpage>1791</fpage><lpage>1798</lpage><year>2016</year><pub-id pub-id-type="pmid">26998078</pub-id><pub-id pub-id-type="pmcid">4774541</pub-id></element-citation></ref>
<ref id="b10-mmr-16-04-4980"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>J</given-names></name><name><surname>Matsushime</surname><given-names>H</given-names></name><name><surname>Hiebert</surname><given-names>SW</given-names></name><name><surname>Ewen</surname><given-names>ME</given-names></name><name><surname>Sherr</surname><given-names>CJ</given-names></name></person-group><article-title>Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4</article-title><source>Genes Dev</source><volume>7</volume><fpage>331</fpage><lpage>342</lpage><year>1993</year><pub-id pub-id-type="doi">10.1101/gad.7.3.331</pub-id><pub-id pub-id-type="pmid">8449399</pub-id></element-citation></ref>
<ref id="b11-mmr-16-04-4980"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leone</surname><given-names>G</given-names></name><name><surname>DeGregori</surname><given-names>J</given-names></name><name><surname>Jakoi</surname><given-names>L</given-names></name><name><surname>Cook</surname><given-names>JG</given-names></name><name><surname>Nevins</surname><given-names>JR</given-names></name></person-group><article-title>Collaborative role of E2F transcriptional activity and G1 cyclindependent kinase activity in the induction of S phase</article-title><source>Proc Natl Acad Sci USA</source><volume>96</volume><fpage>6626</fpage><lpage>6631</lpage><year>1999</year><pub-id pub-id-type="doi">10.1073/pnas.96.12.6626</pub-id><pub-id pub-id-type="pmid">10359762</pub-id><pub-id pub-id-type="pmcid">21965</pub-id></element-citation></ref>
<ref id="b12-mmr-16-04-4980"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>AM</given-names></name><name><surname>Makuuchi</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Cell cycle regulators and human hepatocarcinogenesis</article-title><source>Hepatogastroenterology</source><volume>45</volume><fpage>1635</fpage><lpage>1642</lpage><year>1998</year><pub-id pub-id-type="pmid">9840120</pub-id></element-citation></ref>
<ref id="b13-mmr-16-04-4980"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundarrajan</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Rao</surname><given-names>KV</given-names></name></person-group><article-title>Overexpression of cyclin D1 is associated with the decondensation of chromatin during den-induced sequential hepatocarcinogenesis</article-title><source>Cell Biol Int</source><volume>26</volume><fpage>699</fpage><lpage>706</lpage><year>2002</year><pub-id pub-id-type="doi">10.1006/cbir.2002.0923</pub-id><pub-id pub-id-type="pmid">12175673</pub-id></element-citation></ref>
<ref id="b14-mmr-16-04-4980"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casimiro</surname><given-names>MC</given-names></name><name><surname>Di Sante</surname><given-names>G</given-names></name><name><surname>Ju</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Crosariol</surname><given-names>M</given-names></name><name><surname>Yaman</surname><given-names>I</given-names></name><name><surname>Gormley</surname><given-names>M</given-names></name><name><surname>Meng</surname><given-names>H</given-names></name><name><surname>Lisanti</surname><given-names>MP</given-names></name><name><surname>Pestell</surname><given-names>RG</given-names></name></person-group><article-title>Cyclin D1 promotes androgen-dependent DNA damage repair in prostate cancer cells</article-title><source>Cancer Res</source><volume>76</volume><fpage>329</fpage><lpage>338</lpage><year>2016</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-0999</pub-id><pub-id pub-id-type="pmid">26582866</pub-id></element-citation></ref>
<ref id="b15-mmr-16-04-4980"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Bi</surname><given-names>Z</given-names></name><name><surname>You</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><etal/></person-group><article-title>The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1</article-title><source>Tumour Biol</source><volume>37</volume><fpage>3957</fpage><lpage>3967</lpage><year>2016</year><pub-id pub-id-type="doi">10.1007/s13277-015-4234-0</pub-id><pub-id pub-id-type="pmid">26482614</pub-id></element-citation></ref>
<ref id="b16-mmr-16-04-4980"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(&#x2212;Delta Delta C(T)) method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref>
<ref id="b17-mmr-16-04-4980"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name></person-group><article-title>Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer</article-title><source>Oncotarget</source><volume>6</volume><fpage>1064</fpage><lpage>1078</lpage><year>2015</year><pub-id pub-id-type="doi">10.18632/oncotarget.2833</pub-id><pub-id pub-id-type="pmid">25473900</pub-id></element-citation></ref>
<ref id="b18-mmr-16-04-4980"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>JJ</given-names></name><name><surname>Meng</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>HL</given-names></name><name><surname>Zhou</surname><given-names>QB</given-names></name><name><surname>Deng</surname><given-names>XG</given-names></name><name><surname>Chen</surname><given-names>RF</given-names></name></person-group><article-title>Hepatitis C virus core protein regulates OCT4 expression and promotes cell cycle progression in hepatocellular carcinoma</article-title><source>Oncol Rep</source><volume>36</volume><fpage>582</fpage><lpage>588</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/or.2016.4775</pub-id><pub-id pub-id-type="pmid">27121765</pub-id></element-citation></ref>
<ref id="b19-mmr-16-04-4980"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><article-title>Hallmarks of cancer: The next generation</article-title><source>Cell</source><volume>144</volume><fpage>646</fpage><lpage>674</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref>
<ref id="b20-mmr-16-04-4980"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>G</given-names></name><name><surname>Karin</surname><given-names>M</given-names></name></person-group><article-title>NF-&#x03BA;B and STAT3-key players in liver inflammation and cancer</article-title><source>Cell Res</source><volume>21</volume><fpage>159</fpage><lpage>168</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/cr.2010.183</pub-id><pub-id pub-id-type="pmid">21187858</pub-id></element-citation></ref>
<ref id="b21-mmr-16-04-4980"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>MC</given-names></name><name><surname>Manor</surname><given-names>O</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Mosammaparast</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>JK</given-names></name><name><surname>Lan</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Segal</surname><given-names>E</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name></person-group><article-title>Long noncoding RNA as modular scaffold of histone modification complexes</article-title><source>Science</source><volume>329</volume><fpage>689</fpage><lpage>693</lpage><year>2010</year><pub-id pub-id-type="doi">10.1126/science.1192002</pub-id><pub-id pub-id-type="pmid">20616235</pub-id><pub-id pub-id-type="pmcid">2967777</pub-id></element-citation></ref>
<ref id="b22-mmr-16-04-4980"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Woo</surname><given-names>DH</given-names></name><name><surname>Shin</surname><given-names>Y</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>N</given-names></name><name><surname>Oh</surname><given-names>YT</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Rheey</surname><given-names>J</given-names></name><name><surname>Nakano</surname><given-names>I</given-names></name><etal/></person-group><article-title>Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells</article-title><source>Cancer Cell</source><volume>23</volume><fpage>839</fpage><lpage>852</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.ccr.2013.04.008</pub-id><pub-id pub-id-type="pmid">23684459</pub-id><pub-id pub-id-type="pmcid">4109796</pub-id></element-citation></ref>
<ref id="b23-mmr-16-04-4980"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name></person-group><article-title>Epithelial-mesenchymal transition and cancer stem cells, mediated by a long non-coding RNA, HOTAIR, are involved in cell malignant transformation induced by cigarette smoke extract</article-title><source>Toxicol Appl Pharmacol</source><volume>282</volume><fpage>9</fpage><lpage>19</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.taap.2014.10.022</pub-id><pub-id pub-id-type="pmid">25447409</pub-id></element-citation></ref>
<ref id="b24-mmr-16-04-4980"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>TK</given-names></name><name><surname>Castilho</surname><given-names>A</given-names></name><name><surname>Cheung</surname><given-names>VC</given-names></name><name><surname>Tang</surname><given-names>KH</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Ng</surname><given-names>IO</given-names></name></person-group><article-title>CD24(&#x002B;) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation</article-title><source>Cell Stem Cell</source><volume>9</volume><fpage>50</fpage><lpage>63</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.stem.2011.06.005</pub-id><pub-id pub-id-type="pmid">21726833</pub-id></element-citation></ref>
<ref id="b25-mmr-16-04-4980"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>JJ</given-names></name><name><surname>Chen</surname><given-names>RF</given-names></name><name><surname>Deng</surname><given-names>XG</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>XY</given-names></name><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Zeng</surname><given-names>B</given-names></name><etal/></person-group><article-title>Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway</article-title><source>FEBS Lett</source><volume>588</volume><fpage>566</fpage><lpage>573</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.febslet.2013.11.041</pub-id><pub-id pub-id-type="pmid">24462277</pub-id></element-citation></ref>
<ref id="b26-mmr-16-04-4980"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Gui</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Pu</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>D</given-names></name></person-group><article-title>LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2</article-title><source>Oncotarget</source><volume>6</volume><fpage>27847</fpage><lpage>27864</lpage><year>2015</year><pub-id pub-id-type="doi">10.18632/oncotarget.4443</pub-id><pub-id pub-id-type="pmid">26172293</pub-id><pub-id pub-id-type="pmcid">4695030</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-16-04-4980" position="float">
<label>Figure 1.</label>
<caption><p>Knockdown of <italic>HOTAIR</italic> inhibits Huh7 cell proliferation. (A) mRNA expression levels of <italic>HOTAIR</italic> in Huh7 cells transfected with siHotair, siNC, or Mock transfected with Lipofectamine alone, were detected by reverse transcription-quantitative polymerase chain reaction. (B) Cell proliferation of Huh7 cells in each group was measured by a Cell Counting kit-8 assay. Data are presented as mean &#x00B1; standard deviation of three independent experiments. &#x002A;P&#x003C;0.05 vs. siNC. <italic>HOTAIR</italic>, homeobox transcript antisense RNA gene; siHotair, small interfering RNA targeting <italic>HOTAIR</italic>; siNC, small interfering RNA targeting negative control.</p></caption>
<graphic xlink:href="MMR-16-04-4980-g00.jpg"/>
</fig>
<fig id="f2-mmr-16-04-4980" position="float">
<label>Figure 2.</label>
<caption><p>Knockdown of <italic>HOTAIR</italic> arrests cell cycle of Huh7 cells. Cell cycle analysis of Huh7 cells transfected with (A) Lipofectamine alone (Mock), (B) siNC or (C) siHotair. (D) Cell cycle distribution of Huh7 cells in each group was compared. Data are presented as mean &#x00B1; standard deviation of three independent experiments. &#x002A;P&#x003C;0.05 vs. siNC. <italic>HOTAIR</italic>, homeobox transcript antisense RNA gene; siHotair, small interfering RNA targeting <italic>HOTAIR</italic>; siNC, small interfering RNA targeting negative control.</p></caption>
<graphic xlink:href="MMR-16-04-4980-g01.jpg"/>
</fig>
<fig id="f3-mmr-16-04-4980" position="float">
<label>Figure 3.</label>
<caption><p>Knockdown of <italic>HOTAIR</italic> decreases expression levels of <italic>CCND1</italic> and cyclin D1 in Huh7 cells. Huh7 cells were transfected with Lipofectamine alone (Mock), siHotair or siNC and (A) mRNA expression levels of <italic>CCND1</italic> and (B and C) cyclin D1 protein expression levels were measured. Data are presented as mean &#x00B1; standard deviation of three independent experiments. &#x002A;P&#x003C;0.05 vs. siNC. <italic>HOTAIR</italic>, homeobox transcript antisense RNA gene; siHotair, small interfering RNA targeting <italic>HOTAIR</italic>; siNC, small interfering RNA targeting negative control.</p></caption>
<graphic xlink:href="MMR-16-04-4980-g02.jpg"/>
</fig>
<fig id="f4-mmr-16-04-4980" position="float">
<label>Figure 4.</label>
<caption><p>Knockdown of <italic>HOTAIR</italic> inhibits expression of cyclin D1 and pSTAT3 in Huh7 cells. Expression levels of pSTAT3, total STAT3 and cyclin D1 in Huh7 cells transfected with siHotair or siNC, or Mock transfected with Lipofectamine alone, as determined by (A) western blot analysis and (B) densitometric analysis. Data are presented as mean &#x00B1; standard deviation of three independent experiments. &#x002A;P&#x003C;0.05 vs. siNC. <italic>HOTAIR</italic>, homeobox transcript antisense RNA gene; siHotair, small interfering RNA targeting <italic>HOTAIR</italic>; siNC, small interfering RNA targeting negative control; STAT3, signal transducer and activator of transcription 3; pSTAT3, phosphorylated STAT3.</p></caption>
<graphic xlink:href="MMR-16-04-4980-g03.jpg"/>
</fig>
<fig id="f5-mmr-16-04-4980" position="float">
<label>Figure 5.</label>
<caption><p>Knockdown of <italic>HOTAIR</italic> combined with STAT3 inhibition leads to an additional reduction in cyclin D1 expression. Huh7 cells were treated with the AG490 STAT3 inhibitor for 1 h prior to siHotair transfection, and the expression levels of pSTAT3, total STAT3 and cyclin D1 were detected by (A) western blot analysis and (B) densitometric analysis. Data are presented as mean &#x00B1; standard deviation of three independent experiments. &#x002A;P&#x003C;0.05 vs. siHotair(&#x2212;)AG490(&#x2212;). <italic>HOTAIR</italic>, homeobox transcript antisense RNA gene; siHotair, small interfering RNA targeting <italic>HOTAIR</italic>; siNC, small interfering RNA targeting negative control; STAT3, signal transducer and activator of transcription 3; pSTAT, phosphorylated STAT3.</p></caption>
<graphic xlink:href="MMR-16-04-4980-g04.jpg"/>
</fig>
</floats-group>
</article>
